Mouse models for inherited endocrine and metabolic disorders

Journal of Endocrinology

Volumn 211, Issue 3, 2011, Pages 211-230

  Piret, Siân E ^a   Thakker, Rajesh V ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM SENSING RECEPTOR; CYCLIN DEPENDENT KINASE INHIBITOR; ETHYLNITROSOUREA; KANAMYCIN KINASE; T BOX TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 3;

AUTOSOMAL DOMINANT DISORDER; CHEMICAL MUTAGENESIS; DIGEORGE SYNDROME; DISEASE MODEL; DISEASE SEVERITY; ENDOCRINE TUMOR; FAMILIAL DISEASE; GAIN OF FUNCTION MUTATION; GENE MUTATION; GENE TARGETING; GENOME; GLIA CELL; HEARING IMPAIRMENT; HEREDITARY HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; HYPERPHOSPHATEMIA; HYPOCALCEMIA; HYPOCALCIURIA; HYPOPARATHYROIDISM; IN VITRO STUDY; IN VIVO STUDY; JAW TUMOR; KIDNEY DYSPLASIA; KNOCKOUT GENE; KNOCKOUT MOUSE; LOSS OF FUNCTION MUTATION; MOUSE; MULTIPLE ENDOCRINE NEOPLASIA; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2; MULTIPLE ENDOCRINE NEOPLASIA TYPE 4; MULTIPLE ORGAN FAILURE; NEUROFIBROMATOSIS; NONHUMAN; PHENOTYPE; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; REVIEW; SIPPLE SYNDROME; SPONTANEOUS MUTATION; TRANSGENIC MOUSE;

ANIMALS; CYCLIN-DEPENDENT KINASES; DISEASE MODELS, ANIMAL; ENDOCRINE SYSTEM DISEASES; FEMALE; GENETIC TECHNIQUES; HUMANS; HYPERPARATHYROIDISM; HYPOPARATHYROIDISM; JAW NEOPLASMS; MALE; METABOLISM, INBORN ERRORS; MICE; MICE, KNOCKOUT; MULTIPLE ENDOCRINE NEOPLASIA; MUTAGENESIS; RECEPTORS, CALCIUM-SENSING;

EID: 83455211563     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-11-0193     Document Type: Review

References (145)

1. Acevedo-Arozena A, Wells S, Potter P, Kelly M, Cox RD & Brown SD 2008 ENU mutagenesis, a way forward to understand gene function. Annual Review of Genomics and Human Genetics 9 49-69.
2. Agarwal SK, Mateo CM & Marx SJ 2009 Rare germline mutations in cyclindependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states. Journal of Clinical Endocrinology and Metabolism 94 1826-1834.
3. Aggarwal VS, Carpenter C, Freyer L, Liao J, Petti M & Morrow BE 2010 Mesodermal Tbx1 is required for patterning the proximal mandible in mice. Developmental Biology 344 669-681.
4. Ali A, Christie PT, Grigorieva IV, Harding B, Van Esch H, Ahmed SF, Bitner-Glindzicz M, Blind E, Bloch C, Christin P et al. 2007 Functional characterization of GATA3 mutations causing the hypoparathyroidismdeafness-renal (HDR) dysplasia syndrome: insight into mechanisms of DNA binding by the GATA3 transcription factor. Human Molecular Genetics 16 265-275.
5. Arnold JS, Braunstein EM, Ohyama T, Groves AK, Adams JC, Brown MC & Morrow BE 2006a Tissue-specific roles of Tbx1 in the development of the outer, middle and inner ear, defective in 22q11DS patients. Human Molecular Genetics 15 1629-1639.
6. Arnold JS, Werling U, Braunstein EM, Liao J, Nowotschin S, Edelmann W, Hebert JM & Morrow BE 2006b Inactivation of Tbx1 in the pharyngeal endoderm results in 22q11DS malformations. Development 133 977-987.
7. Bai F, Pei XH, Nishikawa T, Smith MD & Xiong Y 2007 p18Ink4c, but not p27Kip1, collaborates with Men1 to suppress neuroendocrine organ tumors. Molecular and Cellular Biology 27 1495-1504.
8. Barbaric I, Wells S, Russ A & Dear TN 2007 Spectrum of ENU-induced mutations in phenotype-driven and gene-driven screens in the mouse. Environmental and Molecular Mutagenesis 48 124-142.
9. Bassett JH, Rashbass P, Harding B, Forbes SA, Pannett AA & Thakker RV 1999 Studies of the murine homolog of the multiple endocrine neoplasia type 1 (MEN1) gene, men1. Journal of Bone and Mineral Research 14 3-10.
10. Beck L, Soumounou Y, Martel J, Krishnamurthy G, Gauthier C, Goodyer CG & Tenenhouse HS 1997 Pex/PEX tissue distribution and evidence for a deletion in the 30 region of the Pex gene in X-linked hypophosphatemic mice. The Journal of Clinical Investigation 99 1200-1209.
11. Bertolino P, Radovanovic I, Casse H, Aguzzi A, Wang ZQ & Zhang CX 2003a Genetic ablation of the tumor suppressor menin causes lethality at mid-gestation with defects in multiple organs. Mechanisms of Development 120 549-560.
12. Bertolino P, Tong WM, Galendo D, Wang ZQ & Zhang CX 2003b Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1. Molecular Endocrinology 17 1880-1892.
13. Bertolino P, Tong WM, Herrera PL, Casse H, Zhang CX &Wang ZQ 2003c Pancreatic beta-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice. Cancer Research 63 4836-4841.
14. Bilous RW, Murty G, Parkinson DB, Thakker RV, Coulthard MG, Burn J, Mathias D & Kendall-Taylor P 1992 Brief report: autosomal dominant familial hypoparathyroidism, sensorineural deafness, and renal dysplasia. New England Journal of Medicine 327 1069-1074.
15. Biondi CA, Gartside MG, Waring P, Loffler KA, Stark MS, Magnuson MA, Kay GF & Hayward NK 2004 Conditional inactivation of the MEN1 gene leads to pancreatic and pituitary tumorigenesis but does not affect normal development of these tissues. Molecular and Cellular Biology 24 3125-3131.
16. Braunstein EM, Monks DC, Aggarwal VS, Arnold JS & Morrow BE 2009 Tbx1 and Brn4 regulate retinoic acid metabolic genes during cochlear morphogenesis. BMC Developmental Biology 9 31.
17. Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J, Simonds WF, Gillanders EM, Kennedy AM, Chen JD et al. 2002 HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nature Genetics 32 676-680.
18. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA et al. 1997 Positional cloning of the gene for multiple endocrine neoplasiatype 1. Science 276 404-407.
19. Chang W, Tu C, Chen TH, Bikle D & Shoback D 2008 The extracellular calcium-sensing receptor (CaSR) is a critical modulator of skeletal development. Science Signaling 1 ra1.
20. Coghill EL, Hugill A, Parkinson N, Davison C, Glenister P, Clements S, Hunter J, Cox RD & Brown SD 2002 A gene-driven approach to the identification of ENU mutants in the mouse. Nature Genetics 30 255-256.
21. Collins FS, Finnell RH, Rossant J & Wurst W 2007a A new partner for the international knockout mouse consortium. Cell 129 235.
22. Collins FS, Rossant J & Wurst W 2007b A mouse for all reasons. Cell 128 9-13.
23. Crabtree JS, Scacheri PC, Ward JM, Garrett-Beal L, Emmert-Buck MR, Edgemon KA, Lorang D, Libutti SK, Chandrasekharappa SC, Marx SJ et al. 2001 A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. PNAS 98 1118-1123.
24. Crabtree JS, Scacheri PC, Ward JM, McNally SR, Swain GP, Montagna C, Hager JH, Hanahan D, Edlund H, Magnuson MA et al. 2003 Of mice and MEN1: insulinomas in a conditional mouse knockout. Molecular and Cellular Biology 23 6075-6085.
25. Cranston AN & Ponder BA 2003 Modulation of medullary thyroid carcinoma penetrance suggests the presence of modifier genes in a RET transgenic mouse model. Cancer Research 63 4777-4780.
26. Deng C, Zhang P, Harper JW, Elledge SJ & Leder P 1995 Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82 675-684.
27. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, Howe JR, Moley JF, Goodfellow P & Wells SA Jr 1993 Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Human Molecular Genetics 2 851-856.
28. Egbuna OI & Brown EM 2008 Hypercalcaemic and hypocalcaemic conditions due to calcium-sensing receptor mutations. Best Practice and Research. Clinical Rheumatology 22 129-148.
29. Eng C, Clayton D, Schuffenecker I, Lenoir G, Cote G, Gagel RF, van Amstel HK, Lips CJ, Nishisho I, Takai SI et al. 1996 The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. Journal of the American Medical Association 276 1575-1579.
30. Engleka KA, Wu M, Zhang M, Antonucci NB & Epstein JA 2007 Menin is required in cranial neural crest for palatogenesis and perinatal viability. Developmental Biology 311 524-537.
31. Fisher EM, Lana-Elola E, Watson SD, Vassiliou G & Tybulewicz VL 2009 New approaches for modelling sporadic genetic disease in the mouse. Disease Models & Mechanisms 2 446-453.
32. Fontaniere S, Tost J, Wierinckx A, Lachuer J, Lu J, Hussein N, Busato F, Gut I, Wang ZQ & Zhang CX 2006 Gene expression profiling in insulinomas of Men1 beta-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic beta-cell tumorigenesis. Endocrine-Related Cancer 13 1223-1236.
33. Fontaniere S, Duvillie B, Scharfmann R, Carreira C, Wang ZQ & Zhang CX 2008 Tumour suppressor menin is essential for development of the pancreatic endocrine cells. Journal of Endocrinology 199 287-298.
34. Franklin DS, Godfrey VL, Lee H, Kovalev GI, Schoonhoven R, Chen-Kiang S, Su L & Xiong Y 1998 CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes and Development 12 2899-2911.
35. Franklin DS, Godfrey VL, O'Brien DA, Deng C & Xiong Y 2000 Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity. Molecular and Cellular Biology 20 6147-6158.
36. Friedel RH, Plump A, Lu X, Spilker K, Jolicoeur C, Wong K, Venkatesh TR, Yaron A, Hynes M, Chen B et al. 2005 Gene targeting using a promoterless gene trap vector ("targeted trapping") is an efficient method to mutate a large fraction of genes. PNAS 102 13188-13193.
37. Friedman E, Sakaguchi K, Bale AE, Falchetti A, Streeten E, Zimering MB, Weinstein LS, McBrideWO, Nakamura Y, Brandi ML et al. 1989 Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. New England Journal of Medicine 321 213-218.
38. Fritz A, Walch A, Piotrowska K, Rosemann M, Schaffer E, Weber K, Timper A, Wildner G, Graw J, Hofler H et al. 2002 Recessive transmission of a multiple endocrine neoplasia syndrome in the rat. Cancer Research 62 3048-3051.
39. Garner SC, Pi M, Tu Q & Quarles LD 2001 Rickets in cation-sensing receptor-deficient mice: an unexpected skeletal phenotype. Endocrinology 142 3996-4005.
40. Georgitsi M, Raitila A, Karhu A, van der Luijt RB, Aalfs CM, Sane T, Vierimaa O, Makinen MJ, Tuppurainen K, Paschke R et al. 2007 Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia. Journal of Clinical Endocrinology and Metabolism 92 3321-3325.
41. GongW, Emanuel BS, Collins J, Kim DH, Wang Z, Chen F, Zhang G, Roe B & Budarf ML 1996 A transcription map of the DiGeorge and velo-cardiofacial syndrome minimal critical region on 22q11. Human Molecular Genetics 5 789-800.
42. Grigorieva IV, Mirczuk S, Gaynor KU, Nesbit MA, Grigorieva EF, Wei Q, Ali A, Fairclough RJ, Stacey JM, Stechman MJ et al. 2010 Gata3-deficient mice develop parathyroid abnormalities due to dysregulation of the parathyroidspecific transcription factor Gcm2. Journal of Clinical Investigation 120 2144-2155.
43. Grote D, Souabni A, Busslinger M & Bouchard M 2006 Pax 2/8-regulated Gata 3 expression is necessary for morphogenesis and guidance of the nephric duct in the developing kidney. Development 133 53-61.
44. Gunther T, Chen ZF, Kim J, Priemel M, Rueger JM, Amling M, Moseley JM, Martin TJ, Anderson DJ & Karsenty G 2000 Genetic ablation of parathyroid glands reveals another source of parathyroid hormone. Nature 406 199-203.
45. Guru SC, Goldsmith PK, Burns AL, Marx SJ, Spiegel AM, Collins FS & Chandrasekharappa SC 1998 Menin, the product of the MEN1 gene, is a nuclear protein. PNAS 95 1630-1634.
46. Hacking DF 2008 'Knock, and it shall be opened': knocking out and knocking in to reveal mechanisms of disease and novel therapies. Early Human Development 84 821-827.
47. Hall B, Limaye A & Kulkarni AB 2009 Overview: generation of gene knockout mice. Current Protocols in Cell Biology Chapter 19 Unit 19.12 11-17.
48. Harding B, Lemos MC, Reed AA, Walls GV, Jeyabalan J, Bowl MR, Tateossian H, Sullivan N, Hough T, Fraser WD et al. 2009 Multiple endocrine neoplasia type 1 knockout mice develop parathyroid, pancreatic, pituitary and adrenal tumours with hypercalcaemia, hypophosphataemia and hypercorticosteronaemia. Endocrine-Related Cancer 16 1313-1327.
49. Haruyama N, Cho A & Kulkarni AB 2009 Overview: engineering transgenic constructs and mice. Current Protocols in Cell Biology Chapter 19 Unit 19. 10.
50. Haven CJ, Wong FK, van Dam EW, van der Juijt R, van Asperen C, Jansen J, Rosenberg C, de WitM, Roijers J, Hoppener J et al. 2000 A genotypic and histopathological study of a large Dutch kindred with hyperparathyroidismjaw tumor syndrome. Journal of Clinical Endocrinology and Metabolism 85 1449-1454.
51. Hickman-Davis JM & Davis IC 2006 Transgenic mice. Paediatric Respiratory Reviews 7 49-53.
52. Ho C, Conner DA, Pollak MR, Ladd DJ, Kifor O, Warren HB, Brown EM, Seidman JG & Seidman CE 1995 A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nature Genetics 11 389-394.
53. Hobbs MR, Rosen IB & Jackson CE 2002 Revised 14.7-cM locus for the hyperparathyroidism-jaw tumor syndrome gene, HRPT2. American Journal of Human Genetics 70 1376-1377.
54. Hofstra RM, Landsvater RM, Ceccherini I, Stulp RP, Stelwagen T, Luo Y, Pasini B, Hoppener JW, van Amstel HK, Romeo G et al. 1994 A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367 375-376.
55. Hough TA, Bogani D, Cheeseman MT, Favor J, Nesbit MA, Thakker RV & Lyon MF 2004 Activating calcium-sensing receptor mutation in the mouse is associated with cataracts and ectopic calcification. PNAS 101 13566-13571.
56. Hu T, Yamagishi H, Maeda J, McAnally J, Yamagishi C & Srivastava D 2004 Tbx1 regulates fibroblast growth factors in the anterior heart field through a reinforcing autoregulatory loop involving forkhead transcription factors. Development 131 5491-5502.
57. Huang SC, Zhuang Z, Weil RJ, Pack S, Wang C, Krutzsch HC, Pham TA & Lubensky IA 1999 Nuclear/cytoplasmic localization of the multiple endocrine neoplasia type 1 gene product, menin. Laboratory Investigation 79 301-310.
58. Jerome LA & Papaioannou VE 2001 DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nature Genetics 27 286-291.
59. Ji Y, Prasad NB, Novotny EA, Kaur S, Elkahloun A, Chen Y, Zhang RZ, Chu ML, Agarwal SK, Marx SJ et al. 2007 Mouse embryo fibroblasts lacking the tumor suppressor menin show altered expression of extracellular matrix protein genes. Molecular Cancer Research 5 1041-1051.
60. Kantham L, Quinn SJ, Egbuna OI, Baxi K, Butters R, Pang JL, Pollak MR, Goltzman D & Brown EM 2009 The calcium-sensing receptor (CaSR) defends against hypercalcemia independently of its regulation of parathyroid hormone secretion. American Journal of Physiology. Endocrinology and Metabolism 297 E915-E923.
61. Karnik SK, Hughes CM, Gu X, Rozenblatt-Rosen O, McLean GW, Xiong Y, Meyerson M & Kim SK 2005 Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c. PNAS 102 14659-14664.
62. Kawai K, Iwashita T, Murakami H, Hiraiwa N, Yoshiki A, Kusakabe M, Ono K, Iida K, Nakayama A & Takahashi M 2000 Tissue-specific carcinogenesis in transgenic mice expressing the RET proto-oncogene with a multiple endocrine neoplasia type 2A mutation. Cancer Research 60 5254-5260.
63. Kim J, Jones BW, Zock C, Chen Z, Wang H, Goodman CS & Anderson DJ 1998 Isolation and characterization of mammalian homologs of the Drosophila gene glial cells missing. PNAS 95 12364-12369.
64. Kiyokawa H, Kineman RD, Manova-Todorova KO, Soares VC, Hoffman ES, Ono M, Khanam D, Hayday AC, Frohman LA & Koff A 1996 Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85 721-732.
65. Kovacs CS, Ho-Pao CL, Hunzelman JL, Lanske B, Fox J, Seidman JG, Seidman CE & Kronenberg HM 1998 Regulation of murine fetal-placental calcium metabolism by the calcium-sensing receptor. Journal of Clinical Investigation 101 2812-2820.
66. Kos CH, Karaplis AC, Peng JB, Hediger MA, Goltzman D, Mohammad KS, Guise TA & Pollak MR 2003 The calcium-sensing receptor is required for normal calcium homeostasis independent of parathyroid hormone. Journal of Clinical Investigation 111 1021-1028.
67. Kottemann MC & Bale AE 2009 Characterization of DNA damagedependent cell cycle checkpoints in a menin-deficient model. DNA Repair 8 944-952.
68. Lairmore TC, Howe JR, Korte JA, Dilley WG, Aine L, Aine E, Wells SA Jr & Donis-Keller H 1991 Familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2B map to the same region of chromosome 10 as multiple endocrine neoplasia type 2A. Genomics 9 181-192.
69. Lania G, Zhang Z, Huynh T, Caprio C, Moon AM, Vitelli F & Baldini A 2009 Early thyroid development requires a Tbx1-Fgf8 pathway. Developmental Biology 328 109-117.
70. Lapenna S & Giordano A 2009 Cell cycle kinases as therapeutic targets for cancer. Nature Reviews. Drug Discovery 8 547-566.
71. Larsson C, Skogseid B, Oberg K, Nakamura Y & Nordenskjold M 1988 Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332 85-87.
72. Lee J & Kim SS 2009 The function of p27 KIP1 during tumor development. Experimental & Molecular Medicine 41 765-771.
73. Lemmens I, Van de Ven WJ, Kas K, Zhang CX, Giraud S, Wautot V, Buisson N, De Witte K, Salandre J, Lenoir G et al. 1997 Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. Human Molecular Genetics 6 1177-1183.
74. Lemos MC & Thakker RV 2008 Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene. Human Mutation 29 22-32.
75. Lemos MC, Harding B, Reed AA, Jeyabalan J, Walls GV, Bowl MR, Sharpe J, Wedden S, Moss JE, Ross A et al. 2009 Genetic background influences embryonic lethality and the occurrence of neural tube defects in Men1 null mice: relevance to genetic modifiers. Journal of Endocrinology 203 133-142.
76. Libutti SK, Crabtree JS, Lorang D, Burns AL, Mazzanti C, Hewitt SM, O'Connor S, Ward JM, Emmert-Buck MR, Remaley A et al. 2003 Parathyroid gland-specific deletion of the mouse Men1 gene results in parathyroid neoplasia and hypercalcemic hyperparathyroidism. Cancer Research 63 8022-8028.
77. Lim KC, Lakshmanan G, Crawford SE, Gu Y, Grosveld F & Engel JD 2000 Gata3 loss leads to embryonic lethality due to noradrenaline deficiency of the sympathetic nervous system. Nature Genetics 25 209-212.
78. Lindsay EA, Vitelli F, Su H, Morishima M, Huynh T, Pramparo T, Jurecic V, Ogunrinu G, Sutherland HF, Scambler PJ et al. 2001 Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 410 97-101.
79. Liu Z, Yu S & Manley NR 2007 Gcm2 is required for the differentiation and survival of parathyroid precursor cells in the parathyroid/thymus primordia. Developmental Biology 305 333-346.
80. Loffler KA, Biondi CA, Gartside M, Waring P, Stark M, Serewko-Auret MM, Muller HK, Hayward NK & Kay GF 2007 Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1. International Journal of Cancer 120 259-267.
81. Lorenz B, Francis F, Gempel K, Boddrich A, Josten M, SchmahlW, Schmidt J, Lehrach H, Meitinger T & Strom TM 1998 Spermine deficiency in Gy mice caused by deletion of the spermine synthase gene. Human Molecular Genetics 7 541-547.
82. van Looij MA, van der Burg H, van der Giessen RS, de Ruiter MM, van der Wees J, van Doorninck JH, De Zeeuw CI & van Zanten GA 2005 GATA3 haploinsufficiency causes a rapid deterioration of distortion product otoacoustic emissions (DPOAEs) in mice. Neurobiology of Disease 20 890-897.
83. Lu J, Herrera PL, Carreira C, Bonnavion R, Seigne C, Calender A, Bertolino P & Zhang CX 2010 Alpha cell-specific Men1 ablation triggers the transdifferentiation of glucagon-expressing cells and insulinoma development. Gastroenterology 138 1954-1965.
84. Martin-Caballero J, Flores JM, Garcia-Palencia P & Serrano M 2001 Tumor susceptibility of p21(Waf1/Cip1)-deficient mice. Cancer Research 61 6234-6238.
85. Mathew CG, Chin KS, Easton DF, Thorpe K, Carter C, Liou GI, Fong SL, Bridges CD, Haak H, Kruseman AC et al. 1987 A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10. Nature 328 527-528.
86. Meyer RA Jr, Henley CM, Meyer MH, Morgan PL, McDonald AG, Mills C & Price DK 1998 Partial deletion of both the spermine synthase gene and the Pex gene in the X-linked hypophosphatemic, gyro (Gy) mouse. Genomics 48 289-295.
87. Miao D, He B, Karaplis AC & Goltzman D 2002 Parathyroid hormone is essential for normal fetal bone formation. Journal of Clinical Investigation 109 1173-1182.
88. Miao D, He B, Lanske B, Bai XY, Tong XK, Hendy GN, Goltzman D & Karaplis AC 2004 Skeletal abnormalities in Pth-null mice are influenced by dietary calcium. Endocrinology 145 2046-2053.
89. Michiels FM, Chappuis S, Caillou B, Pasini A, Talbot M, Monier R, Lenoir GM, Feunteun J & Billaud M 1997 Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation. PNAS 94 3330-3335.
90. Milne TA, Hughes CM, Lloyd R, Yang Z, Rozenblatt-Rosen O, Dou Y, Schnepp RW, Krankel C, Livolsi VA, Gibbs D et al. 2005 Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. PNAS 102 749-754.
91. Molatore S, Marinoni I, Lee M, Pulz E, Ambrosio MR, degli Uberti EC, Zatelli MC & Pellegata NS 2010 A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization. Human Mutation 31 E1825-E1835.
92. Mulligan LM, Kwok JB, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papi L et al. 1993 Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363 458-460.
93. Muroya K, Hasegawa T, Ito Y, Nagai T, Isotani H, Iwata Y, Yamamoto K, Fujimoto S, Seishu S, Fukushima Y et al. 2001 GATA3 abnormalities and the phenotypic spectrum of HDR syndrome. Journal of Medical Genetics 38 374-380.
94. Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, Horii I & Loh DY 1996 Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85 707-720.
95. Nesbit MA, Bowl MR, Harding B, Ali A, Ayala A, Crowe C, Dobbie A, Hampson G, Holdaway I, Levine MA et al. 2004 Characterization of GATA3 mutations in the hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome. Journal of Biological Chemistry 279 22624-22634.
96. Newey PJ, Bowl MR & Thakker RV 2009 Parafibromin - functional insights. Journal of Internal Medicine 266 84-98.
97. Newey PJ, Bowl MR, Cranston T & Thakker RV 2010 Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors. Human Mutation 31 295-307.
98. Nguyen D & Xu T 2008 The expanding role of mouse genetics for understanding human biology and disease. Disease Models and Mechanisms 1 56-66.
99. Norum RA, Lafreniere RG, O'Neal LW, Nikolai TF, Delaney JP, Sisson JC, Sobol H, Lenoir GM, Ponder BA, Willard HF et al. 1990 Linkage of the multiple endocrine neoplasia type 2B gene (MEN2B) to chromosome 10 markers linked to MEN2A. Genomics 8 313-317.
100. Ozawa A, Agarwal SK, Mateo CM, Burns AL, Rice TS, Kennedy PA, Quigley CM, Simonds WF, Weinstein LS, Chandrasekharappa SC et al. 2007 The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations. Journal of Clinical Endocrinology and Metabolism 92 1948-1951.
101. Pandolfi PP, Roth ME, Karis A, Leonard MW, Dzierzak E, Grosveld FG, Engel JD & Lindenbaum MH 1995 Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis. Nature Genetics 11 40-44.
102. Pearce SH, Williamson C, Kifor O, Bai M, Coulthard MG, Davies M, Lewis-Barned N, McCredie D, Powell H, Kendall-Taylor P et al. 1996 A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. New England Journal of Medicine 335 1115-1122.
103. Pellegata NS, Quintanilla-Martinez L, Siggelkow H, Samson E, Bink K, Hofler H, Fend F, Graw J & Atkinson MJ 2006 Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans. PNAS 103 15558-15563.
104. Piotrowska K, Pellegata NS, Rosemann M, Fritz A, Graw J & Atkinson MJ 2004 Mapping of a novel MEN-like syndrome locus to rat chromosome 4. Mammalian Genome 15 135-141.
105. Pollak MR, Brown EM, Chou YH, Hebert SC, Marx SJ, Steinmann B, Levi T, Seidman CE & Seidman JG 1993 Mutations in the human Ca(2C)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75 1297-1303.
106. Pollak MR, Brown EM, Estep HL, McLaine PN, Kifor O, Park J, Hebert SC, Seidman CE & Seidman JG 1994 Autosomal dominant hypocalcaemia caused by a Ca(2C)-sensing receptor gene mutation. Nature Genetics 8 303-307.
107. Quwailid MM, Hugill A, Dear N, Vizor L, Wells S, Horner E, Fuller S, Weedon J, McMath H, Woodman P et al. 2004 A gene-driven ENU-based approach to generating an allelic series in any gene. Mammalian Genome 15 585-591.
108. Raid R, Krinka D, Bakhoff L, Abdelwahid E, Jokinen E, Karner M, MalvaM, Meier R, Pelliniemi LJ, Ploom M et al. 2009 Lack of Gata3 results in conotruncal heart anomalies in mouse. Mechanisms of Development 126 80-89.
109. Reynolds L, Jones K, Winton DJ, Cranston A, Houghton C, Howard L, Ponder BA & Smith DP 2001 C-cell and thyroid epithelial tumours and altered follicular development in transgenic mice expressing the long isoform of MEN 2A RET. Oncogene 20 3986-3994.
110. Rodriguez L, Tu C, Cheng Z, Chen TH, Bikle D, Shoback D & Chang W 2005 Expression and functional assessment of an alternatively spliced extracellular Ca2C-sensing receptor in growth plate chondrocytes. Endocrinology 146 5294-5303.
111. Rozenblatt-Rosen O, Hughes CM, Nannepaga SJ, Shanmugam KS, Copeland TD, Guszczynski T, Resau JH & Meyerson M 2005 The parafibromin tumor suppressor protein is part of a human Paf1 complex. Molecular and Cellular Biology 25 612-620.
112. Runeberg-Roos P & Saarma M 2007 Neurotrophic factor receptor RET: structure, cell biology, and inherited diseases. Annals of Medicine 39 572-580.
113. Scacheri PC, Crabtree JS, Novotny EA, Garrett-Beal L, Chen A, Edgemon KA, Marx SJ, Spiegel AM, Chandrasekharappa SC & Collins FS 2001 Bidirectional transcriptional activity of PGK-neomycin and unexpected embryonic lethality in heterozygote chimeric knockout mice. Genesis 30 259-263.
114. Scacheri PC, Crabtree JS, Kennedy AL, Swain GP, Ward JM, Marx SJ, Spiegel AM & Collins FS 2004a Homozygous loss of menin is well tolerated in liver, a tissue not affected in MEN1. Mammalian Genome 15 872-877.
115. Scacheri PC, Kennedy AL, Chin K, Miller MT, Hodgson JG, Gray JW, Marx SJ, Spiegel AM & Collins FS 2004b Pancreatic insulinomas in multiple endocrine neoplasia, type I knockout mice can develop in the absence of chromosome instability or microsatellite instability. Cancer Research 64 7039-7044.
116. Shen HC, Rosen JE, Yang LM, Savage SA, Burns AL, Mateo CM, Agarwal SK, Chandrasekharappa SC, Spiegel AM, Collins FS et al. 2008 Parathyroid tumor development involves deregulation of homeobox genes. Endocrine-Related Cancer 15 267-275.
117. Shen HC, He M, Powell A, Adem A, Lorang D, Heller C, Grover AC, Ylaya K, Hewitt SM, Marx SJ et al. 2009 Recapitulation of pancreatic neuroendocrine tumors in human multiple endocrine neoplasia type I syndrome via Pdx1-directed inactivation of Men1. Cancer Research 69 1858-1866.
118. Shen HC, Ylaya K, Pechhold K, Wilson A, Adem A, Hewitt SM & Libutti SK 2010 Multiple endocrine neoplasia type 1 deletion in pancreatic alpha-cells leads to development of insulinomas in mice. Endocrinology 151 4024-4030.
119. Simpson NE, Kidd KK, Goodfellow PJ, McDermid H, Myers S, Kidd JR, Jackson CE, Duncan AM, Farrer LA, Brasch K et al. 1987 Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage. Nature 328 528-530.
120. Smith-Hicks CL, Sizer KC, Powers JF, Tischler AS & Costantini F 2000 C-cell hyperplasia, pheochromocytoma and sympathoadrenal malformation in a mouse model of multiple endocrine neoplasia type 2B. EMBO Journal 19 612-622.
121. Stanford WL, Cohn JB&Cordes SP 2001 Gene-trap mutagenesis: past, present and beyond. Nature Reviews. Genetics 2 756-768.
122. Strom TM, Francis F, Lorenz B, Boddrich A, Econs MJ, Lehrach H & Meitinger T 1997 Pex gene deletions in Gy and Hyp mice provide mouse models forX-linked hypophosphatemia. HumanMolecular Genetics 6 165-171.
123. Sweetser DA, Froelick GJ, Matsumoto AM, Kafer KE, Marck B, Palmiter RD & Kapur RP 1999 Ganglioneuromas and renal anomalies are induced by activated RET(MEN2B) in transgenic mice. Oncogene 18 877-886.
124. Szabo J, Heath B, Hill VM, Jackson CE, Zarbo RJ, Mallette LE, Chew SL, Besser GM, ThakkerRV, Huff V. et al. 1995 Hereditary hyperparathyroidismjaw tumor syndrome: the endocrine tumor gene HRPT2 maps to chromosome 1q21-q31. American Journal of Human Genetics 56 944-950.
125. Teh BT, Farnebo F, Kristoffersson U, Sundelin B, Cardinal J, Axelson R, Yap A, Epstein M, Heath H III, Cameron D et al. 1996 Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas. Journal of Clinical Endocrinology and Metabolism 81 4204-4211.
126. Teh BT, Farnebo F, Twigg S, Hoog A, Kytola S, Korpi-Hyovalti E, Wong FK, Nordenstrom J, Grimelius L, Sandelin K et al. 1998 Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21-q32 in a subset of families. Journal of Clinical Endocrinology and Metabolism 83 2114-2120.
127. Tenenhouse HS 1999 X-linked hypophosphataemia: a homologous disorder in humans and mice. Nephrology, Dialysis, Transplantation 14 333-341.
128. Thakker RV 2004 Diseases associated with the extracellular calcium-sensing receptor. Cell Calcium 35 275-282.
129. Thakker RV 2006 Multiple endocrine neoplasia type 1. In Endocrinology, 5th edn, pp 3509-3531. Eds LJ DeGroot & JL Jameson. Philadelphia: Elsevier Saunders.
130. Thakker RV 2010 Multiple endocrine neoplasia type 1 (MEN1). Best Practice and Research. Clinical Endocrinology and Metabolism 24 355-370.
131. Thakker RV, Bouloux P, Wooding C, Chotai K, Broad PM, Spurr NK, Besser GM & O'Riordan JL 1989 Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11. New England Journal of Medicine 321 218-224.
132. Trump D, Farren B, Wooding C, Pang JT, Besser GM, Buchanan KD, Edwards CR, Heath DA, Jackson CE, Jansen S et al. 1996 Clinical studies of multiple endocrine neoplasia type 1 (MEN1). Quarterly Journal of Medicine 89 653-669.
133. Tu Q, Pi M, Karsenty G, Simpson L, Liu S & Quarles LD 2003 Rescue of the skeletal phenotype in CasR-deficient mice by transfer onto the Gcm2 null background. Journal of Clinical Investigation 111 1029-1037.
134. Van Esch H, Groenen P, Nesbit MA, Schuffenhauer S, Lichtner P, Vanderlinden G, Harding B, Beetz R, Bilous RW, Holdaway I et al. 2000 GATA3 haplo-insufficiency causes human HDR syndrome. Nature 406 419-422.
135. Vargas-Poussou R, Huang C, Hulin P, Houillier P, Jeunemaitre X, Paillard M, Planelles G, Dechaux M, Miller RT & Antignac C 2002 Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. Journal of the American Society of Nephrology 13 2259-2266.
136. Vitelli F, Morishima M, Taddei I, Lindsay EA & Baldini A 2002 Tbx1 mutation causes multiple cardiovascular defects and disrupts neural crest and cranial nerve migratory pathways. Human Molecular Genetics 11 915-922.
137. Walls GV, Bowl MR, Jeyabalan J, Reed AA, Harding B, Ali A, Bradley KJ, Wang P, Chen J, Williams BO et al. 2009 Mice deleted for the hyperparathyroidism-jaw tumour (HPT-JT) syndrome allele have abnormal parathyroids with increased proliferation rates. Endocrine Abstracts 19 OC30.
138. Wang P, Bowl MR, Bender S, Peng J, Farber L, Chen J, Ali A, Zhang Z, Alberts AS, Thakker RV et al. 2008 Parafibromin, a component of the human PAF complex, regulates growth factors and is required for embryonic development and survival in adult mice. Molecular and Cellular Biology 28 2930-2940.
139. Watanabe S, Fukumoto S, Chang H, Takeuchi Y, Hasegawa Y, Okazaki R, Chikatsu N & Fujita T 2002 Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. Lancet 360 692-694.
140. Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, Agarwal P, Agarwala R, Ainscough R, Alexandersson M, An P et al. 2002 Initial sequencing and comparative analysis of the mouse genome. Nature 420 520-562.
141. van derWees J, vanLooijMA, deRuiterMM, EliasH, vanderBurgH, LiemSS, KurekD, Engel JD, Karis A, van Zanten BG. et al. 2004 Hearing loss following Gata3 haploinsufficiency is caused by cochlear disorder. Neurobiology ofDisease 16 169-178.
142. Wohllk N, Schweizer H, Erlic Z, Schmid KW, Walz MK, Raue F & Neumann HP 2010 Multiple endocrine neoplasia type 2. Best Practice and Research. Clinical Endocrinology and Metabolism 24 371-387.
143. Yagi H, Furutani Y, Hamada H, Sasaki T, Asakawa S, Minoshima S, Ichida F, Joo K, Kimura M, Imamura S et al. 2003 Role of TBX1 in human del22q11.2 syndrome. Lancet 362 1366-1373.
144. Yin L, Puliti A, Bonora E, Evangelisti C, Conti V, Tong WM, Medard JJ, Lavoue MF, Forey N, Wang LC et al. 2007 C620R mutation of the murine ret proto-oncogene: loss of function effect in homozygotes and possible gain of function effect in heterozygotes. International Journal of Cancer 121 292-300.
145. Zhang Z, Huynh T & Baldini A 2006 Mesodermal expression of Tbx1 is necessary and sufficient for pharyngeal arch and cardiac outflow tract development. Development 133 3587-3595.